MEASURE DESCRIPTION:
Percentage of diabetic patients, aged 18 years and older, who receive an office-based or ambulatory surgery whose blood glucose level is appropriately managed throughout the perioperative period.
The measure will consist of four performance rates:
**AQI71a: Percentage of patients, aged 18 years and older, with a current diagnosis of diabetes mellitus receiving anesthesia services for office-based or ambulatory surgery whose blood glucose level is tested prior to the start of anesthesia.
**AQI71b: Percentage of patients, aged 18 years and older, with a current diagnosis of diabetes mellitus receiving anesthesia services for office-based or ambulatory surgery who experienced a blood glucose level ≥180 mg/dL (10.0 mmol/L) who received insulin prior to anesthesia end time.
**AQI71c: Percentage of patients, aged 18 years and older, with a current diagnosis of diabetes mellitus receiving anesthesia services for office-based or ambulatory surgery who received insulin perioperatively and who received a follow-up blood glucose level check following the administration of insulin and prior to discharge.
**AQI71d: Percentage of patients, aged 18 years and older, with a current diagnosis of diabetes mellitus receiving anesthesia services for office-based or ambulatory surgery who experienced a blood glucose level ≥180 mg/dL (10.0 mmol/L) who received education on managing their glucose in the postoperative period prior to discharge.
NOTE: The overall measure score will be calculated as an average of the performance rates of parts A, B, C and D. In order to be scored on this measure, clinicians must have at least one eligible case reported for each sub-metric: AQI71a, AQI71b, AQI71c, and AQI71d.
MEASURE ID:
AQI 71
COLLECTION TYPE:
QCDR Measure
HIGH PRIORITY STATUS:
No
MEASURE TYPE:
Process
BENCHMARK:
No *
BENCHMARK TYPE:
* N/A - Insufficient volume of data submitted in PY 2022 to establish historical benchmark.
TOPPED OUT:
N/A
SEVEN POINT CAP:
N/A
AVERAGE PERFORMANCE RATE:
N/A
DECILE RANGE: